Numinus Wellness' CEO is Michael Tan, appointed in Jan 2025, has a tenure of 1.5 years. directly owns 0.76% of the company’s shares, worth $85.26K. The average tenure of the management team and the board of directors is 4.1 years and 5.8 years respectively.
Key information
Michael Tan
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
1.5yrs
CEO ownership
0.8%
Management average tenure
4.1yrs
Board average tenure
5.8yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Michael Tan's remuneration changed compared to Numinus Wellness's earnings?
Date
Total Compensation
Salary
Company Earnings
May 31 2025
n/a
n/a
-CA$13m
Feb 28 2025
n/a
n/a
-CA$16m
Nov 30 2024
n/a
n/a
-CA$12m
Aug 31 2024
CA$472k
CA$288k
-CA$15m
May 31 2024
n/a
n/a
-CA$16m
Feb 29 2024
n/a
n/a
-CA$19m
Nov 30 2023
n/a
n/a
-CA$21m
Aug 31 2023
CA$455k
CA$275k
-CA$23m
May 31 2023
n/a
n/a
-CA$44m
Feb 28 2023
n/a
n/a
-CA$45m
Nov 30 2022
n/a
n/a
-CA$46m
Aug 31 2022
CA$621k
CA$219k
-CA$45m
May 31 2022
n/a
n/a
-CA$28m
Feb 28 2022
n/a
n/a
-CA$26m
Nov 30 2021
n/a
n/a
-CA$22m
Aug 31 2021
CA$605k
CA$223k
-CA$19m
May 31 2021
n/a
n/a
-CA$14m
Feb 28 2021
n/a
n/a
-CA$13m
Nov 30 2020
n/a
n/a
-CA$11m
Aug 31 2020
CA$164k
CA$164k
-CA$10m
May 31 2020
n/a
n/a
-CA$10m
Feb 29 2020
n/a
n/a
-CA$8m
Nov 30 2019
n/a
n/a
-CA$7m
Aug 31 2019
CA$73k
CA$73k
-CA$7m
Compensation vs Market: Insufficient data to establish whether Michael's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.
CEO
Michael Tan
1.5yrs
Tenure
CA$472,058
Compensation
Mr. Michael Tan, MBA, serves as Chief Executive officer since January 2025 at Numinus Wellness Inc. and served as its Chief Operating Officer Since May 15, 2020 until January 2025 and also serves as its Di...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Payton Nyquvest
Founder & Executive Chair
6.2yrs
CA$637.89k
2.63% $ 295.0k
Michael Tan
CEO & Director
1.5yrs
CA$472.06k
0.76% $ 85.3k
Paul Thielking
Chief Science & Medical Officer
4.1yrs
CA$324.60k
no data
Reid Robison
Chief Clinical Officer
4.1yrs
CA$221.51k
no data
Kelvin Yang
Chief Financial Officer
1.4yrs
no data
no data
Ian Noble
Chief Communications Officer
5.2yrs
no data
no data
Lea Bottoni
Vice President of People & Culture
5.1yrs
no data
no data
Judy Varga
Head of Laboratory Operations
5.7yrs
no data
no data
Jason Lapensee
Senior Vice President of Clinic Operations
3.5yrs
no data
no data
4.1yrs
Average Tenure
Experienced Management: NUMI.F's management team is considered experienced (4.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Payton Nyquvest
Founder & Executive Chair
6.2yrs
CA$637.89k
2.63% $ 295.0k
Michael Tan
CEO & Director
6.2yrs
CA$472.06k
0.76% $ 85.3k
Larry Timlick
Independent Director
7.5yrs
CA$40.00k
0.18% $ 20.4k
Dennis McKenna
Member of General Advisory Counsel
5.8yrs
no data
no data
Jamie Wheal
Member of General Advisory Counsel
5.8yrs
no data
no data
Ben Nemtin
Member of General Advisory Counsel
5.8yrs
no data
no data
Pamela Hadfield
Member of General Advisory Counsel
5.8yrs
no data
no data
Nichol Bradford
Member of General Advisory Counsel
5.8yrs
no data
no data
Pam Kryskow
Member of the Clinical Advisory Council
5.7yrs
no data
no data
Gabor Mate
Member of the Clinical Advisory Council
5.7yrs
no data
no data
Kate Browning
Member of the Clinical Advisory Council
5.7yrs
no data
no data
Zachary Walsh
Member of the Clinical Advisory Council
5.7yrs
no data
no data
5.8yrs
Average Tenure
Experienced Board: NUMI.F's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/07 01:49
End of Day Share Price
2026/07/07 00:00
Earnings
2025/05/31
Annual Earnings
2024/08/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Numinus Wellness Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.